|  | Total N | Number of Comparisons | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Follow-up Time (Months) | ||||||||||
Comparison | RCTs | 1 | 2 | 3 | 6 | 9 | 12 | 24 | 36 | |
Ablation & LNG-IUS | 7 | 422 | Â | Â | 1 | 2 | Â | 7 | 2 | 1 |
COC & Danazol | 1 | 24 | Â | 1 | Â | Â | Â | Â | Â | Â |
COC & Placebo | 2 | 355 | 2 | 2 | 2 | 2 | Â | Â | Â | Â |
COC & LNG-IUS | 2 | 91 | Â | Â | 1 | 1 | 1 | 2 | Â | Â |
Danazol & Prog < 2 wks | 3 | 72 | 1 | 1 | 3 | Â | Â | Â | Â | Â |
Placebo & TXA | 1 | 166 | Â | Â | 1 | Â | Â | Â | Â | Â |
LNG-IUS & Prog < 2 wks | 1 | 162 | Â | Â | 1 | 1 | Â | Â | Â | Â |
LNG-IUS & Prog ~ 3 wks | 1 | 38 | 1 | Â | 1 | Â | Â | Â | Â | Â |
LNG-IUS & TXA | 1 | 31 | Â | Â | Â | Â | Â | Â | Â | Â |
Prog < 2 wks & TXA | 1 | 46 | 1 | 1 | Â | Â | Â | Â | Â | Â |
Prog ~ 3 wks & TXA | 1 | 94 | Â | Â | 1 | Â | Â | Â | Â | Â |